Insider

Richard Daniell

EVP, Europe Commercial · Teva Pharmaceutical Industries Ltd (TEVA)

sold: $1,928,944 · planned sales: $1,928,944

DateTradeSharesAvg. priceValueFiling
November 11, 2026Planned sale20,003—$856,155SEC
November 11, 2026Sale45,003$42.86$1,928,944SEC
November 9, 2026Planned sale25,000—$1,072,789SEC

Shown: open-market purchases and sales (Form 4, codes P and S) and notices of planned sales (Form 144), values as filed. Not shown: grants, tax withholding, gifts and option exercises — they are not trades. A disclosed trade does not show how the person rates the company and is not a recommendation.